Elsea, S. H. Et Al. 2020. ASAH1pathogenic variants associated with acid ceramidase deficiency: Farber disease and spinal muscular atrophy with progressive myoclonic epilepsy. HUMAN MUTATION , vol.41, no.9 , 1469-1487.

Elsea, S. H., Solyom, A., Martin, K., Harmatz, P., Mitchell, J., Lampe, C., ... Grant, C.(2020). ASAH1pathogenic variants associated with acid ceramidase deficiency: Farber disease and spinal muscular atrophy with progressive myoclonic epilepsy. HUMAN MUTATION , vol.41, no.9, 1469-1487.

Elsea, Sarah Et Al. "ASAH1pathogenic variants associated with acid ceramidase deficiency: Farber disease and spinal muscular atrophy with progressive myoclonic epilepsy," HUMAN MUTATION , vol.41, no.9, 1469-1487, 2020

Elsea, Sarah H. Et Al. "ASAH1pathogenic variants associated with acid ceramidase deficiency: Farber disease and spinal muscular atrophy with progressive myoclonic epilepsy." HUMAN MUTATION , vol.41, no.9, pp.1469-1487, 2020

Elsea, S. H. Et Al. (2020) . "ASAH1pathogenic variants associated with acid ceramidase deficiency: Farber disease and spinal muscular atrophy with progressive myoclonic epilepsy." HUMAN MUTATION , vol.41, no.9, pp.1469-1487.

@article{article, author={Sarah H. Elsea Et Al. }, title={ASAH1pathogenic variants associated with acid ceramidase deficiency: Farber disease and spinal muscular atrophy with progressive myoclonic epilepsy}, journal={HUMAN MUTATION}, year=2020, pages={1469-1487} }